In a groundbreaking step toward canine longevity, California-based biotech firm Loyal has achieved partial approval from the U.S. Food and Drug Administration (FDA) for its lifespan-extending drug, LOY-001. Veuer’s Maria Mercedes Galuppo has the story.
